MeiraGTx Holdings plc

Healthcare · Biotechnology · United States

Last price 9.705 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 932.10M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xerostomia, as well as for Sjogren’s syndrome; AAV-GAD in Phase 2 trial for Parkinson’s disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal ...